View our Joint Working Project (JWP) case studies.

Preview of Penguin patient management system - demonstration video

Novartis Pharmaceuticals UK Ltd are partnering with NHS organisations through Joint Working to introduce this software solution from Cievert Ltd (manufacturer) to support patient care.

See more

Preview of The Hammersmith Hospital Myeloproliferative Neoplasm (MPN) Service Database JWP

The Hammersmith Hospital Myeloproliferative Neoplasm (MPN) Service Database JWP.

Download

Preview of The NHS Greater Glasgow & Clyde (GGC) molecular diagnostic pathway development JWP and industry engagement with the Scottish genetics laboratories

The NHS Greater Glasgow & Clyde (GGC) molecular diagnostic pathway development JWP and industry engagement with the Scottish genetics laboratories.

Download

 

 

Preview of The North Central London Sickle and Thalassaemia Network (the Network) Service Development JWP

The North Central London Sickle and Thalassaemia Network (the Network) Service Development JWP.

Download

Preview of Nottingham University Hospital: Joint Working Partnership with Novartis in melanoma and renal cell carcinoma

Nottingham University Hospital:
Joint Working Partnership with Novartis in melanoma and renal cell carcinoma.

Download

Preview of UCLH Cancer Collaborative: Novartis Joint Working Agreement

UCLH Cancer Collaborative:
Novartis Joint Working Agreement.

Download

 

 

Preview of Investigating the inequalities of access to sBC treatment in Greater Manchester (GM) – a JWP with Novartis

Investigating the inequalities of access to sBC treatment in Greater Manchester (GM) – a JWP with Novartis.

Download

 

JWP, joint working project; UCLH, University College London Hospitals.

Rate this content: 
No votes yet
UK | February 2022 | 156894-1
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]